Brief: Disc Medicine Announces Completion Of Enrollment Of Phase 3 Apollo Trial Of Bitopertin In Erythropoietic Protoporphyria
26/03/2026 20:48
March 26 (Reuters) - Disc Medicine Inc IRON.O: DISC MEDICINE ANNOUNCES COMPLETION OF ENROLLMENT OF PHASE 3 APOLLO TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA DISC MEDICINE INC - APOLLO STUDY RESULTS EXPECTED IN Q4 2026 Source text: ID:nGNX8dj77L Further company coverage: IRON.O ((Reuters.Briefs@thomsonreuters.com;))